AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Bid | 85.25 |
Market Cap | 109.16B |
Revenue (ttm) | - |
Net Income (ttm) | - |
EPS (ttm) | 3.27 |
PE Ratio (ttm) | 26.03 |
Forward PE | n/a |
Analyst | Hold |
Ask | 85.44 |
Volume | 10,576,759 |
Avg. Volume (20D) | 6,195,950 |
Open | 83.39 |
Previous Close | 81.79 |
Day's Range | 83.11 - 85.31 |
52-Week Range | 75.96 - 92.68 |
Beta | undefined |
About MDT
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides ...
Analyst Forecast
According to 15 analyst ratings, the average rating for MDT stock is "Hold." The 12-month stock price forecast is $93.5, which is an increase of 9.83% from the latest price.
Next Earnings Release
Analysts project revenue of $8.33B, reflecting a 2.98% YoY growth and earnings per share of 1.36, making a 4.62% increase YoY.
1 month ago · seekingalpha.com
Buy 1 December Aristocrat Of 67 From 38 With 'Safer' Dividends"Dividend Aristocrats